stem cell therapy

This post examines dramatic changes seen in venous blood gases (VBG’s) following stem cell therapy in CFS which coincides clinically with improved skin turgor occurring with the first stem cell transfusion and continuing over time. Notable is the observation of improved skin turgor and “looking younger” which we get from many family members on observing the post-stem cell CFS cases. What is clear clinically is that they are having better microcirculation and you can see it in their faces.

We are now close to 20 CFS patients who have received stem cell transfusions primarily in Panama at SCI and coming up on 8 with 12-18 months of follow-up in June. We have three functional cures (KPS of 75-80) both clinically and by ETM, all under 36 years of age (N=3). A KPS of 75 means they can work full time with accommodation and 80 means they can work full time without accommodation in their job of choice. All three started at KPS’s of 50(2) to 60(1). Two of these functional cures have been sick for almost 20 years, one for 8 years, two are male and one is female. By summer, I hope to be in a position to publish the overall results at one year of follow-up. The early effects following stem cell transfusions are not that impressive functionally until about three to six months out, earlier for those under 40 and later for those over 40. All, however, show significant……

Three family members, mother, son and daughter, all with CFS, were evaluated recently in my clinic. They all became sick in Prague, the Czech Republic, on the mothers sabbatical LOA from her college teaching position after all had a chicken-pox like illness. They are all seven months out from stem cell therapy in Panama. They all have improved significantly following stem cell therapy with the daughter claiming a complete cure after 17 years of illness at the age of 29. She is the second stem cell patient claiming a complete cure and includes an unrelated 23 year old male patient, also 7 months out from stem cells. Both cures took at least 90 days to become manifest with the first thirty days exhibiting significant hypersomnolence and with little energy to do much and typical for all the CFS stem cell patients (N=13).

As of May 2009, we have now evaluated two post-stem cell patients, now three months out from their afterbirth derived stem cell transfusions in February 2009. Below is a summary of their findings through February 2009.

To me, CFS is best viewed as a very complex terrain issue and that microbes are simply taking advantage of this fact so that reductionism to drugs or pharmaceuticals directed against single agents or pathways will be a poor therapeutic choice except perhaps early in the illness and in the occasional patient who is much less complex.